1. |
姜兆磊, 梅举, 汤敏, 等. “一站式”左心耳夹闭术联合经导管主动脉瓣置换术治疗主动脉瓣病变合并心房颤动. 中国胸心血管外科临床杂志, 2022, 29(5): 560-564.
|
2. |
Spears J, Al-Saiegh Y, Goldberg D, et al. TAVR: A review of current practices and considerations in low-risk patients. J Interv Cardiol, 2020, 2020: 2582938.
|
3. |
Avvedimento M, Tang GHL. Transcatheter aortic valve replacement (TAVR): Recent updates. Prog Cardiovasc Dis, 2021, 69: 73-83.
|
4. |
Rudziński PN, Mach M, Gross C, et al. Complex transcatheter aortic valve replacement in aortic regurgitation and transcatheter mitral annuloplasty in severe dextrocardia. Eur J Cardiothorac Surg, 2021, 60(4): 997-999.
|
5. |
Tarantini G, Rodinò G. Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone. Catheter Cardiovasc Interv, 2022, 99(5): 1609-1610.
|
6. |
Koch R, Inci E, Grubb K, et al. A comparison of thirty-day clinical and echocardiographic outcomes of patients undergoing transcatheter vs. surgical aortic valve replacement for native aortic insufficiency. Cardiovasc Revasc Med, 2023, 46: 85-89.
|
7. |
Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: Mechanisms: Part 1 of 2. Circulation, 2013, 128(4): 388-400.
|
8. |
Wong M, Staszewsky L, Latini R, et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol, 2004, 43(11): 2022-2027.
|
9. |
Parikh PB, Tsigkas G, Kalogeropoulos AP. Transcatheter aortic valve replacement after heart failure hospitalization: Too little, too late? Eur J Heart Fail, 2020, 22(10): 1875-1877.
|
10. |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2017, 135(25): e1159-e1195.
|
11. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e35-e71.
|
12. |
Barth M, Selig JI, Klose S, et al. Degenerative aortic valve disease and diabetes: Implications for a link between proteoglycans and diabetic disorders in the aortic valve. Diab Vasc Dis Res, 2019, 16(3): 254-269.
|
13. |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
|
14. |
Lindman BR, Arnold SV, Bagur R, et al. Priorities for patient-centered research in valvular heart disease: A report from the National Heart, Lung, and Blood Institute Working Group. J Am Heart Assoc, 2020, 9(9): e015975.
|
15. |
Nakatsuma K, Taniguchi T, Morimoto T, et al. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis. Heart, 2019, 105(5): 384-390.
|
16. |
Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation, 2004, 109(19): 2302-2308.
|
17. |
Lai HC, Lai HC, Lee WL, et al. Impact of chronic advanced aortic regurgitation on the perioperative outcome of noncardiac surgery. Acta Anaesthesiol Scand, 2010, 54(5): 580-588.
|
18. |
Hashimoto G, Enriquez-Sarano M, Stanberry LI, et al. Association of left ventricular remodeling assessment by cardiac magnetic resonance with outcomes in patients with chronic aortic regurgitation. JAMA Cardiol, 2022, 7(9): 924-933.
|
19. |
Matsumura Y, Hoshikawa-Nagai E, Kubo T, et al. Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy. Am J Cardiol, 2013, 111(1): 106-110.
|
20. |
Barfuss SB, Boucek DM, McFarland CA, et al. Short-term left ventricular reverse remodeling after transcatheter aortic valve replacement in children. J Am Soc Echocardiogr, 2022, 35(10): 1077-1083.
|